1. Home
  2. RIGL vs CODI Comparison

RIGL vs CODI Comparison

Compare RIGL & CODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RIGL
  • CODI
  • Stock Information
  • Founded
  • RIGL 1996
  • CODI 2005
  • Country
  • RIGL United States
  • CODI United States
  • Employees
  • RIGL N/A
  • CODI N/A
  • Industry
  • RIGL Biotechnology: Pharmaceutical Preparations
  • CODI Home Furnishings
  • Sector
  • RIGL Health Care
  • CODI Consumer Discretionary
  • Exchange
  • RIGL Nasdaq
  • CODI Nasdaq
  • Market Cap
  • RIGL 537.6M
  • CODI 480.0M
  • IPO Year
  • RIGL 2000
  • CODI 2006
  • Fundamental
  • Price
  • RIGL $41.76
  • CODI $5.89
  • Analyst Decision
  • RIGL Buy
  • CODI Buy
  • Analyst Count
  • RIGL 6
  • CODI 2
  • Target Price
  • RIGL $39.83
  • CODI $26.00
  • AVG Volume (30 Days)
  • RIGL 652.5K
  • CODI 1.4M
  • Earning Date
  • RIGL 11-04-2025
  • CODI 10-29-2025
  • Dividend Yield
  • RIGL N/A
  • CODI 17.39%
  • EPS Growth
  • RIGL 2698.26
  • CODI N/A
  • EPS
  • RIGL 6.20
  • CODI N/A
  • Revenue
  • RIGL $282,076,000.00
  • CODI $2,198,233,000.00
  • Revenue This Year
  • RIGL $59.93
  • CODI $15.09
  • Revenue Next Year
  • RIGL N/A
  • CODI $8.26
  • P/E Ratio
  • RIGL $6.77
  • CODI N/A
  • Revenue Growth
  • RIGL 79.13
  • CODI 11.87
  • 52 Week Low
  • RIGL $14.63
  • CODI $5.45
  • 52 Week High
  • RIGL $43.72
  • CODI $24.32
  • Technical
  • Relative Strength Index (RSI)
  • RIGL 69.92
  • CODI 40.04
  • Support Level
  • RIGL $34.00
  • CODI $5.45
  • Resistance Level
  • RIGL $39.56
  • CODI $6.11
  • Average True Range (ATR)
  • RIGL 2.35
  • CODI 0.41
  • MACD
  • RIGL 1.10
  • CODI -0.07
  • Stochastic Oscillator
  • RIGL 93.00
  • CODI 28.61

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

About CODI D/B/A Compass Diversified Holdings Shares of Beneficial Interest

Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.

Share on Social Networks: